Investing Profile

Chris Nave

InvestorVC
Managing Director at Brandon Capital Partners
Photo of Chris Nave, Managing Director at Brandon Capital Partners
cb
Brandon Capital Partners Managing Director
$100K - $5.0M
$1.5M
18
$404.5M
CompanyStageDateRound SizeTotal Raised
Denteric
GrantJul 2022
Series ASep 2019$9M
$9M
Ena Respiratory
Series UnknownJun 2021$24M
Series ASep 2020$8M
Series UnknownMay 2017$5M
$37M
Co-investors: Christopher Smith (Brandon Capital Partners)
Azura Ophthalmics
Series COct 2020$20M
Series BOct 2017$16M
$36M
Co-investors: Heather Preston
EBR Systems
Private EquityAug 2019$30M
Private EquityNov 2017$50M
$140M
Co-investors: Jason Lettmann (Morgenthaler Ventures)
Certa Therapeutics
GrantJun 2018$19M
$19M
OccuRx
Series UnknownMay 2015$5M
$5M
Spinifex Pharmaceuticals
Series CApr 2014$45M
Series BAug 2011$19M
Series ASep 2008$10M
Series AJul 2005$2M
$76M
Co-investors: Brent Ahrens (Canaan Partners), Heath Lukatch (Red Tree Venture Capital)
PolyActiva
Series BFeb 2013$10M
$10M